See more : Cargotec Corporation (CYJBF) Income Statement Analysis – Financial Results
Complete financial analysis of American Bio Medica Corporation (ABMC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of American Bio Medica Corporation, a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- Canadian Imperial Bank of Commerce (CM.TO) Income Statement Analysis – Financial Results
- Satu Visi Putra Tbk. (VISI.JK) Income Statement Analysis – Financial Results
- RPMGlobal Holdings Limited (RPGHF) Income Statement Analysis – Financial Results
- Navitas Petroleum, Limited Partnership (NVPT.TA) Income Statement Analysis – Financial Results
- Tsit Wing International Holdings Limited (2119.HK) Income Statement Analysis – Financial Results
American Bio Medica Corporation (ABMC)
About American Bio Medica Corporation
American Bio Medica Corporation engages in manufacture and sale of lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids. Its drugs detection products in urine include Rapid Drug Screen, a rapid drug test, which detects the presence or absence of 2 to 10 drugs; RDS InCup, a drug-testing cup that detects the presence or absence of 1 to 12 drugs; Rapid TOX, a drug test in a cassette platform, which detects the presence or absence of 1 to 10 drugs; and Rapid TOX Cup II, a drug testing cup that detects the presence or absence of 1 to 16 drugs. The company also offers OralStat, a drug test for the detection of drugs in oral fluids, as well as private labeled versions of OralStat. In addition, the company distributes other products for the detection of substances of abuse, as well as products to detect certain infectious diseases. Further, it provides strip contract manufacturing, assembly, and packaging services to non-affiliated diagnostic companies. The company serves rehabilitation/drug treatment, pain management, other clinical, government, and employment/workplace markets. It operates in the United States, Europe, the Asia Pacific, and South America. The company was formerly known as American Micro Media, Inc. and changed its name to American Bio Medica Corporation in September 1992. American Bio Medica Corporation was incorporated in 1986 and is based in Kinderhook, New York.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 913.00K | 2.22M | 4.15M | 3.66M | 3.87M | 4.91M | 5.61M | 6.32M | 7.29M | 8.89M | 9.34M | 9.27M | 10.42M | 9.73M | 12.66M | 13.87M | 13.84M | 13.02M | 12.24M | 12.48M | 10.31M | 0.00 | 7.65M | 7.04M | 2.20M | 610.88K |
| Cost of Revenue | 1.11M | 1.67M | 2.91M | 2.47M | 2.58M | 2.92M | 3.12M | 3.46M | 4.22M | 5.32M | 6.00M | 5.40M | 6.31M | 5.61M | 7.40M | 8.14M | 7.04M | 6.97M | 5.65M | 5.48M | 4.48M | 0.00 | 3.60M | 3.36M | 1.10M | 259.86K |
| Gross Profit | -193.00K | 548.00K | 1.24M | 1.18M | 1.29M | 2.00M | 2.49M | 2.86M | 3.06M | 3.57M | 3.34M | 3.88M | 4.11M | 4.12M | 5.26M | 5.73M | 6.80M | 6.05M | 6.59M | 7.01M | 5.84M | 0.00 | 4.05M | 3.68M | 1.10M | 351.01K |
| Gross Profit Ratio | -21.14% | 24.71% | 29.85% | 32.39% | 33.26% | 40.64% | 44.39% | 45.20% | 42.03% | 40.16% | 35.79% | 41.80% | 39.42% | 42.31% | 41.57% | 41.31% | 49.16% | 46.45% | 53.87% | 56.13% | 56.59% | 0.00% | 52.93% | 52.32% | 50.00% | 57.46% |
| Research & Development | 85.00K | 85.00K | 90.00K | 82.00K | 93.00K | 117.00K | 184.00K | 148.00K | 228.00K | 645.00K | 207.00K | 223.00K | 297.00K | 418.00K | 563.00K | 669.00K | 606.00K | 683.00K | 606.00K | 639.00K | 297.00K | 0.00 | 799.00K | 336.00K | 200.00K | 74.98K |
| General & Administrative | 917.00K | 1.34M | 1.28M | 1.24M | 1.41M | 1.51M | 1.50M | 1.77M | 1.94M | 2.34M | 2.24M | 2.02M | 2.32M | 2.32M | 2.58M | 2.83M | 2.62M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 137.00K | 304.00K | 493.00K | 459.00K | 545.00K | 680.00K | 1.06M | 1.16M | 1.11M | 1.72M | 1.83M | 1.78M | 2.03M | 2.05M | 2.75M | 3.09M | 3.33M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.05M | 1.64M | 1.77M | 1.70M | 1.96M | 2.19M | 2.56M | 2.93M | 3.05M | 4.06M | 4.07M | 3.80M | 4.35M | 4.37M | 5.32M | 5.92M | 5.95M | 5.70M | 5.64M | 5.49M | 4.79M | 0.00 | 5.22M | 5.04M | 5.30M | 867.90K |
| Other Expenses | -90.00K | 677.00K | -173.00K | -93.00K | -264.00K | 38.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 106.00K | 25.00K | 100.00K | 96.13K |
| Operating Expenses | 1.05M | 1.73M | 1.86M | 1.78M | 2.05M | 2.31M | 2.75M | 3.08M | 3.28M | 4.70M | 4.27M | 4.02M | 4.64M | 4.79M | 5.89M | 6.59M | 6.55M | 6.39M | 6.25M | 6.13M | 5.09M | 0.00 | 6.13M | 5.40M | 5.60M | 1.04M |
| Cost & Expenses | 2.16M | 3.40M | 4.77M | 4.25M | 4.63M | 5.23M | 5.87M | 6.54M | 7.50M | 10.03M | 10.27M | 9.42M | 10.96M | 10.40M | 13.28M | 14.73M | 13.59M | 13.36M | 11.90M | 11.61M | 9.56M | 0.00 | 9.73M | 8.76M | 6.70M | 1.30M |
| Interest Income | 3.00K | 194.00K | 175.00K | 265.00K | 1.00K | 0.00 | 0.00 | 0.00 | 0.00 | 2.00K | 1.00K | 0.00 | 1.00K | 1.00K | 3.00K | 9.00K | 7.00K | 5.00K | 8.00K | 32.00K | 34.00K | 0.00 | 84.00K | 103.00K | 103.00K | 0.00 |
| Interest Expense | 194.00K | 194.00K | 175.00K | 265.00K | 284.00K | 272.00K | 284.00K | 206.00K | 244.00K | 310.00K | 194.00K | 198.00K | 216.00K | 203.00K | 213.00K | 149.00K | 67.00K | 55.00K | 53.00K | 78.00K | 58.00K | 0.00 | 21.00K | 7.00K | 7.00K | 0.00 |
| Depreciation & Amortization | 51.00K | 68.00K | 79.00K | 81.00K | 81.00K | 80.00K | 91.00K | 91.00K | 111.00K | 116.00K | 123.00K | 277.00K | 289.00K | 336.00K | 353.00K | 437.00K | 376.00K | 378.00K | 269.00K | 168.00K | 154.00K | 0.00 | 106.00K | 78.00K | 100.00K | 96.13K |
| EBITDA | -1.16M | -199.00K | -540.00K | -340.00K | -661.00K | -193.00K | 34.00K | 180.00K | -133.00K | -360.00K | -796.00K | 140.00K | -241.00K | -360.00K | -283.00K | -401.00K | 627.00K | 38.00K | 615.00K | 1.05M | 903.00K | 0.00 | -1.98M | -1.97M | -1.60M | -4.40M |
| EBITDA Ratio | -127.38% | -19.57% | -14.97% | -16.22% | -19.68% | -3.93% | -2.96% | -2.15% | -1.46% | -11.39% | -8.62% | 1.41% | -2.34% | -3.44% | -2.13% | -3.09% | 4.46% | 0.18% | 4.91% | 6.80% | 9.09% | 0.00% | -24.16% | -22.35% | -204.55% | -117.60% |
| Operating Income | -1.24M | -1.18M | -621.00K | -593.00K | -762.00K | -311.00K | -257.00K | -226.00K | -217.00K | -1.13M | -929.00K | -146.00K | -534.00K | -672.00K | -626.00K | -856.00K | 251.00K | -340.00K | 346.00K | 879.00K | 749.00K | 0.00 | -2.08M | -1.72M | -4.50M | -688.00K |
| Operating Income Ratio | -136.04% | -53.16% | -14.97% | -16.22% | -19.68% | -6.33% | -4.58% | -3.58% | -2.98% | -12.72% | -9.94% | -1.57% | -5.12% | -6.91% | -4.95% | -6.17% | 1.81% | -2.61% | 2.83% | 7.04% | 7.26% | 0.00% | -27.14% | -24.42% | -204.55% | -112.63% |
| Total Other Income/Expenses | -166.00K | 718.00K | -173.00K | -93.00K | -264.00K | -234.00K | -84.00K | -318.00K | -271.00K | 345.00K | -184.00K | -189.00K | -212.00K | -227.00K | -223.00K | -131.00K | -50.00K | -35.00K | -31.00K | 0.00 | -30.00K | 0.00 | 510.00K | -59.00K | 1.70M | 3.94M |
| Income Before Tax | -1.41M | -461.00K | -794.00K | -686.00K | -1.03M | -545.00K | -341.00K | -331.00K | -488.00K | -786.00K | -1.11M | -335.00K | -746.00K | -899.00K | -849.00K | -987.00K | 201.00K | -375.00K | 315.00K | 879.00K | 719.00K | 0.00 | -2.14M | -1.79M | -4.40M | -561.50K |
| Income Before Tax Ratio | -154.22% | -20.78% | -19.15% | -18.77% | -26.50% | -11.09% | -6.08% | -5.24% | -6.70% | -8.84% | -11.91% | -3.61% | -7.16% | -9.24% | -6.71% | -7.12% | 1.45% | -2.88% | 2.57% | 7.04% | 6.97% | 0.00% | -27.91% | -25.39% | -200.00% | -91.92% |
| Income Tax Expense | 2.00K | 2.00K | 2.00K | -5.00K | 2.00K | 234.00K | 4.00K | 2.00K | 2.00K | 2.00K | -2.00K | 10.00K | 4.00K | 1.00K | 1.00K | 3.00K | 5.00K | 1.00K | 49.00K | -428.00K | 6.00K | 0.00 | 160.00K | 33.00K | -200.00K | -309.18K |
| Net Income | -1.41M | -463.00K | -796.00K | -681.00K | -1.03M | -545.00K | -345.00K | -333.00K | -490.00K | -788.00K | -1.11M | -345.00K | -750.00K | -900.00K | -850.00K | -990.00K | 196.00K | -376.00K | 266.00K | 1.03M | 719.00K | 0.00 | -2.14M | -1.69M | -4.40M | -505.32K |
| Net Income Ratio | -154.44% | -20.87% | -19.19% | -18.63% | -26.55% | -11.09% | -6.15% | -5.27% | -6.73% | -8.86% | -11.89% | -3.72% | -7.20% | -9.25% | -6.72% | -7.14% | 1.42% | -2.89% | 2.17% | 8.26% | 6.97% | 0.00% | -27.91% | -24.03% | -200.00% | -82.72% |
| EPS | -0.03 | -0.01 | -0.02 | -0.02 | -0.03 | -0.02 | -0.01 | -0.01 | -0.02 | -0.04 | -0.05 | -0.02 | -0.03 | -0.04 | -0.04 | -0.05 | 0.01 | -0.02 | 0.01 | 0.05 | 0.03 | 0.00 | -0.14 | -0.12 | -0.37 | -0.04 |
| EPS Diluted | -0.03 | -0.01 | -0.02 | -0.02 | -0.03 | -0.02 | -0.01 | -0.01 | -0.02 | -0.04 | -0.05 | -0.02 | -0.03 | -0.04 | -0.04 | -0.05 | 0.01 | -0.02 | 0.01 | 0.05 | 0.03 | 0.00 | -0.14 | -0.12 | -0.37 | -0.04 |
| Weighted Avg Shares Out | 48.02M | 42.76M | 35.56M | 32.53M | 30.12M | 29.21M | 27.46M | 25.68M | 23.34M | 22.27M | 21.83M | 21.74M | 21.74M | 21.74M | 21.74M | 21.74M | 21.48M | 21.31M | 21.19M | 20.62M | 20.61M | 20.61M | 15.48M | 14.67M | 12.00M | 12.73M |
| Weighted Avg Shares Out (Dil) | 48.02M | 42.76M | 35.56M | 32.53M | 30.12M | 29.21M | 27.46M | 25.68M | 23.34M | 22.27M | 21.83M | 21.74M | 21.74M | 21.74M | 21.74M | 21.74M | 21.57M | 21.43M | 21.74M | 21.27M | 21.33M | 21.33M | 15.48M | 14.67M | 12.00M | 12.73M |
HealthToday Unveils eBook on Diabetes Management Featuring Renowned Nutrition Experts
American Beacon Launches Natural Resources ETF
ABMC Reports Second Quarter 2021 Results
American Beacon Advisors Unveils New American Beacon SSI Alternative Income Fund
Source: https://incomestatements.info
Category: Stock Reports